Bal Pharma, leading manufacturer of niche & specialty API, Intermediates and Finished Formulations.
01 3Bal Pharma
02 6Dr. Reddy's Laboratories
03 4Cohance Lifesciences
04 3Breckenridge Pharmaceutical
05 1Octavius Pharma Pvt. Ltd
06 3Pharmathen SA
07 1Adamed Pharma
08 4Alembic Pharmaceuticals Limited
09 2Alhavi Pharma
10 3Alkem Laboratories
11 5Anwita Drugs
12 6Apotex Inc
13 6Arrotex Pharmaceuticals
14 3Ascent Innovative Medicines
15 54Boehringer Ingelheim GmbH
16 3CHEMO
17 3DOC Generici
18 3EG Spa
19 3Farm Agon
20 3Glenmark Pharmaceuticals
21 3Hetero Drugs
22 3Laboratorio Eczane Pharma
23 1Lee Pharma
24 1Loxim Industries
25 3MSN Laboratories
26 1Murli Krishna Pharma
27 1ORIFARM GROUP AS
28 3Orchid Pharma
29 2Pantson Pharma Pvt. Limited
30 5Pharmacore Inc
31 3Precise Group
32 12Sandoz B2B
33 4Spirig Healthcare
34 3Teva Pharmaceutical Industries
35 3Titan Laboratories
36 2Unichem Laboratories Limited
37 2Viatris
01 5CAP
02 9CAPSULE
03 33CAPSULE;ORAL
04 9Caps
05 23Capsule
06 3Capsule - Pellet
07 15Capsule, hard
08 1Dabigatran 110Mg 10 Units Oral Use
09 1Dabigatran 110Mg 30 Joined' Oral Use
10 1Dabigatran 110Mg 60 Units Oral Use
11 1Dabigatran 150Mg 60 Units Oral Use
12 1Dabigatran 75Mg 10 Units Oral Use
13 1Dabigatran 75Mg 30 Joined' Oral Use
14 3HARD CAPSULES
15 6Hard Capsule
16 6Hard Capsules
17 3Kaps
18 3Kapsel, hard
19 3Oral Solid Dosage Form
20 2PELLET
21 6PELLETS;ORAL
22 1Pellets For Capsule
23 1Pellets for Capsules
24 1Pellets for capsules
25 1Sustain Release Pellet
26 5Tablet
27 22capsule
28 5Blank
01 6Generic
02 3Generic EU CTD
03 3Lead Market Dossiers- Filed
04 5Originator
05 32RX
06 122Blank
01 3APO-DABIGATRAN
02 6ARX-Dabigatran
03 30DABIGATRAN ETEXILATE MESYLATE
04 3DABIGATRAN ETEXYLATED DOC
05 3DABIGATRAN ETEXYLATED EG STADA
06 1Dabexa
07 1Dabexa
08 3Dabidane
09 4Dabigatran
10 9Dabigatran Sandoz
11 4Dabigatran Spirig HC
12 3Dabigatran etexilate Sandoz
13 5PHARMACOR DABIGATRAN
14 15PRADAXA
15 38Pradaxa
16 2Pradaxa 110 mg
17 1Pradaxa 150 mg
18 2Pradaxa 75 mg
19 38Blank
01 3Argentina
02 26Australia
03 6Canada
04 3Greece
05 35India
06 2Iran
07 15Italy
08 18Norway
09 1Poland
10 5South Africa
11 3Spain
12 3Sweden
13 12Switzerland
14 39USA
Bal Pharma, leading manufacturer of niche & specialty API, Intermediates and Finished Formulations.
Regulatory Info :
Registration Country : India
Brand Name : Dabigatran
Dosage Form : Capsule
Dosage Strength : 150MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : India
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
Regulatory Info : RX
Registration Country : USA
Brand Name : DABIGATRAN ETEXILATE MESYLATE
Dosage Form : CAPSULE;ORAL
Dosage Strength : EQ 75MG BASE
Packaging :
Approval Date : 2025-01-28
Application Number : 208048
Regulatory Info : RX
Registration Country : USA
Cohance Lifesciences, offers full range of CDMO services for small molecule APIs, intermediates, ADCs, Pellets and Formulations.
Regulatory Info :
Registration Country : India
Brand Name :
Dosage Form : Capsule
Dosage Strength : 75MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : India
Regulatory Info : RX
Registration Country : USA
Brand Name : DABIGATRAN ETEXILATE MESYLATE
Dosage Form : CAPSULE;ORAL
Dosage Strength : EQ 75MG BASE
Packaging :
Approval Date : 2024-12-19
Application Number : 207922
Regulatory Info : RX
Registration Country : USA
Octavius has been empowering lives since 1980 by providing quality products like DC granules, APIs and FDFs.
Regulatory Info :
Registration Country : India
Brand Name : Dabigatran
Dosage Form : Pellets for Capsules
Dosage Strength : 35; 40%; %
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : India
Pharmathen provides life cycle Management solutions for branded pharma, as well as to develop & establish new technology platforms.
Regulatory Info :
Registration Country : Greece
Brand Name :
Dosage Form : Hard Capsule
Dosage Strength : 75MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Greece
Bal Pharma, leading manufacturer of niche & specialty API, Intermediates and Finished Formulations.
Regulatory Info :
Registration Country : India
Brand Name : Dabigatran
Dosage Form : Capsule
Dosage Strength : 110MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : India
Bal Pharma, leading manufacturer of niche & specialty API, Intermediates and Finished Formulations.
Regulatory Info :
Registration Country : India
Brand Name : Dabigatran
Dosage Form : Capsule
Dosage Strength : 75MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : India
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
Regulatory Info : RX
Registration Country : USA
Brand Name : DABIGATRAN ETEXILATE MESYLATE
Dosage Form : CAPSULE;ORAL
Dosage Strength : EQ 110MG BASE
Packaging :
Approval Date : 2025-01-28
Application Number : 208048
Regulatory Info : RX
Registration Country : USA
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
Regulatory Info : RX
Registration Country : USA
Brand Name : DABIGATRAN ETEXILATE MESYLATE
Dosage Form : CAPSULE;ORAL
Dosage Strength : EQ 150MG BASE
Packaging :
Approval Date : 2025-01-28
Application Number : 208048
Regulatory Info : RX
Registration Country : USA
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
Regulatory Info : Lead Market Dossiers- Filed
Registration Country : India
Brand Name :
Dosage Form : Oral Solid Dosage Form
Dosage Strength : 75MG
Packaging :
Approval Date :
Application Number :
Regulatory Info : Lead Market Dossiers- Filed
Registration Country : India
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
Regulatory Info : Lead Market Dossiers- Filed
Registration Country : India
Brand Name :
Dosage Form : Oral Solid Dosage Form
Dosage Strength : 110MG
Packaging :
Approval Date :
Application Number :
Regulatory Info : Lead Market Dossiers- Filed
Registration Country : India
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
Regulatory Info : Lead Market Dossiers- Filed
Registration Country : India
Brand Name :
Dosage Form : Oral Solid Dosage Form
Dosage Strength : 150MG
Packaging :
Approval Date :
Application Number :
Regulatory Info : Lead Market Dossiers- Filed
Registration Country : India
Cohance Lifesciences, offers full range of CDMO services for small molecule APIs, intermediates, ADCs, Pellets and Formulations.
Regulatory Info :
Registration Country : India
Brand Name :
Dosage Form : Capsule
Dosage Strength : 110MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : India
Cohance Lifesciences, offers full range of CDMO services for small molecule APIs, intermediates, ADCs, Pellets and Formulations.
Regulatory Info :
Registration Country : India
Brand Name :
Dosage Form : Capsule
Dosage Strength : 150MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : India
Cohance Lifesciences, offers full range of CDMO services for small molecule APIs, intermediates, ADCs, Pellets and Formulations.
Regulatory Info :
Registration Country : India
Brand Name :
Dosage Form : Sustain Release Pellet
Dosage Strength : 35%
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : India
Regulatory Info : RX
Registration Country : USA
Brand Name : DABIGATRAN ETEXILATE MESYLATE
Dosage Form : CAPSULE;ORAL
Dosage Strength : EQ 150MG BASE
Packaging :
Approval Date : 2024-12-19
Application Number : 207922
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : DABIGATRAN ETEXILATE MESYLATE
Dosage Form : CAPSULE;ORAL
Dosage Strength : EQ 110MG BASE
Packaging :
Approval Date : 2024-12-19
Application Number : 207922
Regulatory Info : RX
Registration Country : USA
Pharmathen provides life cycle Management solutions for branded pharma, as well as to develop & establish new technology platforms.
Regulatory Info :
Registration Country : Greece
Brand Name :
Dosage Form : Hard Capsule
Dosage Strength : 110MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Greece
Pharmathen provides life cycle Management solutions for branded pharma, as well as to develop & establish new technology platforms.
Regulatory Info :
Registration Country : Greece
Brand Name :
Dosage Form : Hard Capsule
Dosage Strength : 150MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Greece
Regulatory Info : RX
Registration Country : USA
Brand Name : DABIGATRAN ETEXILATE MESYLATE
Dosage Form : CAPSULE;ORAL
Dosage Strength : EQ 75MG BASE
Packaging :
Approval Date : 2020-03-11
Application Number : 208040
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : PRADAXA
Dosage Form : CAPSULE;ORAL
Dosage Strength : EQ 75MG BASE
Packaging :
Approval Date : 2010-10-19
Application Number : 22512
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : PRADAXA
Dosage Form : CAPSULE;ORAL
Dosage Strength : EQ 150MG BASE
Packaging :
Approval Date : 2010-10-19
Application Number : 22512
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : PRADAXA
Dosage Form : CAPSULE;ORAL
Dosage Strength : EQ 110MG BASE
Packaging :
Approval Date : 2015-11-20
Application Number : 22512
Regulatory Info : RX
Registration Country : USA
Regulatory Info :
Registration Country : USA
Brand Name : DABIGATRAN ETEXILATE MESYLATE
Dosage Form : CAPSULE;ORAL
Dosage Strength : EQ 75MG BASE
Packaging :
Approval Date :
Application Number : 207984
Regulatory Info :
Registration Country : USA
Regulatory Info :
Registration Country : USA
Brand Name : DABIGATRAN ETEXILATE MESYLATE
Dosage Form : CAPSULE;ORAL
Dosage Strength : EQ 110MG BASE
Packaging :
Approval Date :
Application Number : 207984
Regulatory Info :
Registration Country : USA
Regulatory Info :
Registration Country : USA
Brand Name : DABIGATRAN ETEXILATE MESYLATE
Dosage Form : CAPSULE;ORAL
Dosage Strength : EQ 150MG BASE
Packaging :
Approval Date :
Application Number : 207984
Regulatory Info :
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : DABIGATRAN ETEXILATE MESYLATE
Dosage Form : CAPSULE;ORAL
Dosage Strength : EQ 75MG BASE
Packaging :
Approval Date : 2020-05-06
Application Number : 207961
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : DABIGATRAN ETEXILATE MESYLATE
Dosage Form : CAPSULE;ORAL
Dosage Strength : EQ 150MG BASE
Packaging :
Approval Date : 2020-05-06
Application Number : 207961
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : DABIGATRAN ETEXILATE MESYLATE
Dosage Form : CAPSULE;ORAL
Dosage Strength : EQ 110MG BASE
Packaging :
Approval Date : 2024-08-13
Application Number : 207961
Regulatory Info : RX
Registration Country : USA
